AJR Am J Roentgenol

1. HE P, Chen C, Dong HD, Chen MY, et al
   Vision Language Models for Ultrasound Assessment of Suspicious Axillary Lymph Nodes in Breast Cancer.
   AJR Am J Roentgenol. 2026 Jul 22. doi: 10.2214/AJR.26.35227.
   

   >> Share

   
   

   
   Am J Clin Oncol

2. FATIMA F, Bhatti MI, Raza A, Mirza A, et al
   Safety and Efficacy of Palbociclib and Endocrine Therapy Versus Endocrine Therapy Alone in HR+/HER 2- Breast Cancer Patients; a Systematic Review and Meta-Analysis.
   Am J Clin Oncol. 2026 Jul 20. doi: 10.1097/COC.0000000000001354.
   

   >> Share

   
   

   
   Ann Surg Oncol

3. HAGER MG, Day CN, Corbin KS, Boughey JC, et al
   ASO Visual Abstract: Impact of Omission of Sentinel Lymph Node Surgery on Radiation Treatment in Patients Age 50 Years and Older with Breast Cancer Treated with Lumpectomy: A Single-Institution Retrospective Review.
   Ann Surg Oncol. 2026 Jul 18. doi: 10.1245/s10434-026-20214.
   

   >> Share

   
   
4. MOKHBER A, Lim DW
   ASO Author Reflections: The Overlooked Burden of Decision Regret After Mastectomy for Breast Cancer.
   Ann Surg Oncol. 2026 Jul 18. doi: 10.1245/s10434-026-20274.
   

   >> Share

   
   
5. PRATHIBHA S, Day CN, Black DM, Boughey JC, et al
   ASO Visual Abstract: Evolution of Axillary Surgical Management of Patients with Occult Breast Cancer with Axillary Metastasis.
   Ann Surg Oncol. 2026 Jul 19. doi: 10.1245/s10434-026-20218.
   

   >> Share

   
   
6. MOKHBER A, Tang K, Situ O, O'Neill AC, et al
   ASO Visual Abstract: Association between Decision Regret and Psychosocial Outcomes Following Surgery Among Women with Unilateral Nonhereditary Breast Cancer.
   Ann Surg Oncol. 2026 Jul 19. doi: 10.1245/s10434-026-20246.
   

   >> Share

   
   
7. SERRES S, Zaveri S
   ASO Author Reflections on "Variation in Surgical Management of Stage IV Breast Cancer: Local/Institutional and Regional Geographic Considerations.".
   Ann Surg Oncol. 2026 Jul 19. doi: 10.1245/s10434-026-20273.
   

   >> Share

   
   
8. OMRANIPOUR R, Eslami B, Alipour S, Nazarian N, et al
   The Role of Locoregional Treatment in Non-Progressive De Novo Metastatic Breast Cancer under Systemic Treatment: A Randomized Controlled Trial (LTMBC).
   Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20187.
   

   >> Share

   
   
9. SFARAD HK, Avisar E
   ASO Author Reflections: Imaging-Driven Breast Cancer Surgery-Are We Overlooking Specificity in Our Pursuit of Sensitivity?
   Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20287.
   

   >> Share

   
   
10. SETO A, Port E, Bernik S, Sheng T, et al
    Preoperative Radiologic Assessment of the Axilla in Locally Advanced Breast Cancer After Neoadjuvant Systemic Therapy: A Contemporary Comparison.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20257.
    

    >> Share

    
    
11. CASTRO HERNANDEZ L, Carpenter DJ, Julian TB, Coopey SB, et al
    ASO Visual Abstract: Functional Outcomes for Breast Cancer Survivors following an Intense Resistance Training Program based on Surgical Management of the Breast and Axilla.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20215.
    

    >> Share

    
    
12. RADEMACHER N, Broman KK, Gutnik LA
    ASO Author Reflections: Navigating Axillary Management for Residual Nodal Disease after Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20194.
    

    >> Share

    
    
13. JAEN DM, Millen JC
    ASO Author Reflections: Rethinking Axillary Management in cN2-cN3 Breast Cancer.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20249.
    

    >> Share

    
    
14. VARMAN PM
    ASO Author Reflections: Rethinking Clinical Nodal Staging in Breast Cancer.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20179.
    

    >> Share

    
    
15. CASTRO HERNANDEZ L, Carpenter DJ, Julian TB, Coopey SB, et al
    ASO Author Reflections: Beyond Surgical Extent: Expanding Access to Resistance Training in Breast Cancer Survivorship.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20262.
    

    >> Share

    
    
16. ZHANG L, Kinkade S, Margenthaler JA
    ASO Author Reflections: What Extent of Axillary Surgery Counts? Rethinking Total and Positive Lymph Node Counts After Neoadjuvant Chemotherapy in Young Women with Node-Positive Breast Cancer.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20298.
    

    >> Share

    
    
17. HAGER MG, Day CN, Corbin KS, Boughey JC, et al
    Impact of Omission of Sentinel Lymph Node Surgery on Radiation Treatment in Patients Age 50 and Older with Breast Cancer Treated with Lumpectomy: A Single-Institution Retrospective Review.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20148.
    

    >> Share

    
    
18. KOPKASH K, Piltin M, Jakub J, Javid S, et al
    ASO Visual Abstract: A Prospective, Multi-Center Randomized Controlled Trial (RCT) of the da Vinci SP Surgical System Versus Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20251.
    

    >> Share

    
    
19. YOO JW, Byeon J, Park WK, Kim J, et al
    ASO Visual Abstract: Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20224.
    

    >> Share

    
    

    
    BMC Cancer

20. PARK SY, Kim YJ, Chae H, Choi YJ, et al
    Information-seeking experiences during genetic testing and counseling: a qualitative study of patients at high risk for hereditary breast cancer.
    BMC Cancer. 2026 Jul 21. doi: 10.1186/s12885-026-16538.
    

    >> Share

    
    
21. GAO J, Wang S, Zhang Z, Li J, et al
    Retraction Note: Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients' survival by downregulating miR-21.
    BMC Cancer. 2026;26:870.
    

    >> Share

    
    

    
    Breast Cancer

22. REVENEAU MF, De Pauw A, Masliah-Planchon J, Decees A, et al
    BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.
    Breast Cancer. 2026 Jul 24. doi: 10.1007/s12282-026-01898.
    

    >> Share

    
    
23. WANG Z, Xie Y, Zhang W, Song X, et al
    Reevaluating sentinel lymph node biopsy in older adults with T1 HR+/HER2- breast cancer: a SEER competing risk and nomogram study.
    Breast Cancer. 2026 Jul 23. doi: 10.1007/s12282-026-01896.
    

    >> Share

    
    
24. ALTUNDAG K
    Generalizability and reproducibility challenges in morphometric assessment of nuclear atypia in breast cancer.
    Breast Cancer. 2026 Jul 21. doi: 10.1007/s12282-026-01894.
    

    >> Share

    
    

    
    Breast Cancer (Auckl)

25. NAOWASET P
    Robotic Assisted Versus Conventional Open Nipple Sparing Mastectomy With Implant Based Reconstruction for Breast Cancer: A Systematic Review of Oncologic Outcomes and Surgical Safety.
    Breast Cancer (Auckl). 2026;20:11782234261470560.
    

    >> Share

    
    

    
    Breast Cancer (Dove Med Press)

26. WANG S, Gao C, Wang Q, Xu J, et al
    Expression Profiling of SWI/SNF Complex Subunits in Triple-Negative Breast Cancer Using Tissue Microarray and Immunohistochemistry.
    Breast Cancer (Dove Med Press). 2026;18:606605.
    

    >> Share

    
    

    
    Breast Cancer Res

27. HOLM KY, Mohammed Y, Gunnarsdottir Thormar V, Eiriksson FF, et al
    Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.
    Breast Cancer Res. 2026 Jul 18. doi: 10.1186/s13058-026-02348.
    

    >> Share

    
    
28. ALEIXO G, Hwang WT, Sharma R, Jung W, et al
    The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies.
    Breast Cancer Res. 2026 Jul 21. doi: 10.1186/s13058-026-02350.
    

    >> Share

    
    
29. DING Y, Yu J, Liu M, Liu X, et al
    Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.
    Breast Cancer Res. 2026 Jul 21. doi: 10.1186/s13058-026-02349.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

30. NISHIMURA M, Kogawa T, Sugiyama K, Ozaki Y, et al
    Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B).
    Breast Cancer Res Treat. 2026;218:18.
    

    >> Share

    
    
31. KOCO L, Sanderink WBG, Prokop M, Mann RM, et al
    Factors influencing discussion duration in breast cancer multidisciplinary team meetings: insights for streamlining care.
    Breast Cancer Res Treat. 2026;218:17.
    

    >> Share

    
    
32. KRASNOW NA, Salans M, Jayaraj M, Kuwahara K, et al
    Clinical and molecular features of resected breast cancer brain metastases: a single center retrospective cohort study.
    Breast Cancer Res Treat. 2026;218:16.
    

    >> Share

    
    
33. 
    2026 RISE UP for Breast Cancer and Women's Health Conference.
    Breast Cancer Res Treat. 2026;217.
    

    >> Share

    
    
34. MAYER EL, Collin SM, Hillman S, Berrocal-Almanza LC, et al
    Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study.
    Breast Cancer Res Treat. 2026;218:15.
    

    >> Share

    
    
35. IMANISHI S, Tanaka N, Takeuchi C, Kittaka N, et al
    Age-dependent relative and absolute benefit of radiotherapy after breast-conserving surgery: a population-based analysis using SEER data.
    Breast Cancer Res Treat. 2026;218:19.
    

    >> Share

    
    

    
    Breast J

36. WANG W, Liu J, Wei Y, Fang Y, et al
    Serum IL2Ralpha as a Diagnostic Biomarker and Its Functional Interplay With IL-2 in Breast Cancer.
    Breast J. 2026;2026:e5295439.
    

    >> Share

    
    

    
    Cancer Lett

37. ZHANG J, Miao N, Guo Y, Liu Y, et al
    Targeting tumor cell-intrinsic POU4F1 enhances antitumor immunity and sensitizes tumors to immunotherapy in basal-like breast cancer by modulating macrophage recruitment and polarization.
    Cancer Lett. 2026 Jul 23:218763. doi: 10.1016/j.canlet.2026.218763.
    

    >> Share

    
    

    
    Clin Breast Cancer

38. FILIPITS M, Gruber V, Singer CF, Fitzal F, et al
    The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.
    Clin Breast Cancer. 2026;26:112-120.
    

    >> Share

    
    
39. RIAZ N, AbuOddus N, Peturson H, Warnberg F, et al
    Breast Cancer Location Predicts Sentinel Lymph Node Metastasis in Clinically Node Negative Patients With Invasive Breast Cancer Treated With Upfront Surgery.
    Clin Breast Cancer. 2026;26:90-95.
    

    >> Share

    
    
40. MIYAZAKI T, Kuranishi F, Ohno T
    Additional Landmark and RMST Analyses Addressing Immortal Time Bias in the Evaluation of Autologous Formalin-Fixed Tumor Vaccine for Metastatic Breast Cancer.
    Clin Breast Cancer. 2026;26:80-81.
    

    >> Share

    
    

    
    Eur J Cancer

41. KOIKE Y, Kumamaru H, Iwamoto T, Kinukawa N, et al
    Efficacy of adjuvant chemotherapy for triple-negative early breast cancer with tumor size?
    Eur J Cancer. 2026;245:116932.
    

    >> Share

    
    

    
    Eur J Surg Oncol

42. KOISTINEN R, Aaltonen RI, Juhanoja E, Tamminen A, et al
    Axillary lymph node status following non-identification of the sentinel lymph node in breast cancer.
    Eur J Surg Oncol. 2026;52:112002.
    

    >> Share

    
    
43. EVANS D, Fairhurst K, Griffin C, Brunsden S, et al
    Variation in practice and provision of contralateral symmetrising mastectomy after unilateral mastectomy for breast cancer: A UK national practice survey.
    Eur J Surg Oncol. 2026;52:111993.
    

    >> Share

    
    

    
    Exp Cell Res

44. PENG R, Zhan Y, Cheng Z, Li A, et al
    Targeting the MAPK/ERK Signaling Pathway: Mechanistic Analysis of Pexidartinib in Overcoming Adriamycin Resistance in Breast Cancer.
    Exp Cell Res. 2026 Jul 23:115127. doi: 10.1016/j.yexcr.2026.115127.
    

    >> Share

    
    

    
    Int J Cancer

45. KANG J, Jung W, Kim B, Cho H, et al
    Mid- and Long-Term Risk of Venous Thromboembolism Among Female Breast Cancer Survivors: A Nationwide Cohort Study.
    Int J Cancer. 2026 Jul 22. doi: 10.1002/ijc.70662.
    

    >> Share

    
    

    
    Int J Oncol

46. PILCO-FERRETO N, Calaf GM
    [Corrigendum] Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
    Int J Oncol. 2026;69:110.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

47. WRIGHT JL, Ko K, Kenworthy W, Bosch W, et al
    Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial.
    Int J Radiat Oncol Biol Phys. 2026 Jul 21:S0360-3016(26)03915.
    

    >> Share

    
    

    
    J Clin Oncol

48. OFFERSEN BV, Alsner J, Hogsbjerg K, Nielsen HM, et al
    Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1.
    J Clin Oncol. 2026 Jul 23:JCO2502705. doi: 10.1200/JCO-25-02705.
    

    >> Share

    
    

    
    J Natl Cancer Inst

49. PARK B, Yoon J, Jeon S, Nguyen THT, et al
    Association between smoking habits and breast density, changes in breast density, and breast cancer in Asian women.
    J Natl Cancer Inst. 2026 Jul 21:djag231. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

50. SANTORO CN, Day CN, Sturz-Ellis JL, Hieken TJ, et al
    Contralateral Prophylactic Mastectomy at the Time of Therapeutic Mastectomy for Local Recurrence of Breast Cancer: Influence of Genetic Testing and Other Factors.
    J Surg Oncol. 2026 Jul 21. doi: 10.1002/jso.70339.
    

    >> Share

    
    

    
    NPJ Breast Cancer

51. BATOON L, Muthyala RS, Wang X, Rodman E, et al
    Novel (Z)-endoxifen-related new chemical entities exhibit potent anti-cancer activity in ERalpha+ breast cancer.
    NPJ Breast Cancer. 2026 Jul 20. doi: 10.1038/s41523-026-01007.
    

    >> Share

    
    
52. HAGGSTROM L, Middleton K, Parker A, Segara D, et al
    The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.
    NPJ Breast Cancer. 2026 Jul 21. doi: 10.1038/s41523-026-01008.
    

    >> Share

    
    

    
    Oncol Rep

53. XU W, Kang S, Xin S, Wu Y, et al
    Multidimensional molecular mechanisms of drug resistance in breast cancer: Implications for clinical decision?making and treatment strategies (Review).
    Oncol Rep. 2026;56:162.
    

    >> Share

    
    

    
    PLoS One

54. STEPANIAN J, Mejia-Garcia A, Orozco C, Duitama J, et al
    Breast cancer clustering integrating complete gene expression profiles and genetic ancestry.
    PLoS One. 2026;21:e0352514.
    

    >> Share

    
    
55. GRIBAUDO G, Fornari C, Antonazzo IC, Generali D, et al
    Decision tree model to assess consequences and costs associated with therapy administration pathways for patients with HER2+ breast cancer in Italian oncological centers.
    PLoS One. 2026;21:e0351548.
    

    >> Share

    
    
56. LIU Y, Cao WM, Jin Y, Xu W, et al
    Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC.
    PLoS One. 2026;21:e0354524.
    

    >> Share

    
    
57. 
    Correction: miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
    PLoS One. 2026;21:e0354115.
    

    >> Share

    
    
58. ARAFAT HM, Ali A, Tengku Din TADAA, Shamallakh OM, et al
    Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0354728.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

59. LE NN, Li W, Wilmes LJ, Onishi N, et al
    Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment.
    Radiol Imaging Cancer. 2026;8:e250606.
    

    >> Share

    
    

    
    Radiology

60. MCCABE MP, Wakelin EA, Louis LD, Ng AY, et al
    Closing the Performance Gap between Generalists and Breast Imaging Specialists Using a Nationally Deployed AI Workflow for Screening Mammography.
    Radiology. 2026;320:e252005.
    

    >> Share

    
    
61. SCHIAFFINO S, Cozzi A
    Real-world Lessons for AI in Breast Cancer Screening: One Size Does Not Fit All.
    Radiology. 2026;320:e261852.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share